Oscar Health, Inc.
Company Stats
- Market Cap
- $9.5B
- as of Sep 30, 2026
- Shares Outstanding
- 308.6M
- Free Float
- 72.7%
Income Statement
- Revenue
- $11.7B
- Operating Income
- -$396.4M
- Net Income
- -$443.2M
- EBITDA
- -$367.5M
- Revenue Growth, 3Y
- 43.5%
- FCF Margin, 3Y Avg
- 4.8%
- FCF Margin, Worst Year
- -5.1%
Cash Flow
- Free Cash Flow
- $1.1B
- FCF Yield
- 11.1%
- Owner FCF Yield
- 10.2%
Balance Sheet
- Cash & Equivalents
- $2.8B
Returns & Capital
- SBC, 3Y Avg
- $119.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $11.7B | $1.1B | 9.0% |
| FY2024 | $9.2B | $950.3M | 10.4% |
| FY2023 | $5.9B | -$297.7M | -5.1% |
| FY2022 | $4.0B | $351.3M | 8.9% |
| FY2021 | $1.8B | -$207.6M | -11.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges